Phibro Animal Health Corp. is pursuing patent protection after what it calls a “significant advance in the ongoing development of a vaccine for African swine fever (ASF).”

The Teaneck, New Jersey-based animal health company said its vaccine development process “involves the identification of immunogenic epitopes and proteins that show strong…